2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other
1
Gastrointestinal
1
Conditions
Cardiovascular Diseases
3
Breast Neoplasms
3
Metabolic Syndrome
2
Sarcoidosis
1
Rectal Neoplasms
1
Obesity
1
Non-alcoholic Fatty Liver Disease
1
Lymphoma, Large B-Cell, Diffuse
1
Lung Neoplasms
1
Lung Diseases, Interstitial
1
Liver Cirrhosis
1
Hodgkin Disease
1
Fatigue
1
Colorectal Neoplasms
1
Cardiotoxicity
1
Breast Diseases
1
Interventions
Fluorouracil
497
Bevacizumab
476
Oxaliplatin
449
Leucovorin
440
Irinotecan
408
Cetuximab
317
Capecitabine
317
pembrolizumab
142
Folfox protocol
129
Panitumumab
117
regorafenib
105
Colonoscopy
88
Nivolumab
81
IFL protocol
81
Drug Therapy
77
trifluridine tipiracil drug combination
73
Radiotherapy
66
HMPL-013
65
Blood Specimen Collection
52
Gemcitabine
49
Specimen Handling
46
Neoadjuvant Therapy
45
Standard of Care
44
Magnetic Resonance Spectroscopy
43
Biopsy
43
Chemotherapy, Adjuvant
41
Trifluridine
40
atezolizumab
38
Surveys and Questionnaires
38
Cyclophosphamide
38
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Colorectal Neoplasms
×
Blood Pressure
×
Clear all
NCT03663062
2020-11-04
OSCAR
South Tyneside and Sunderland NHS Foundation Trust
Completed
1,430 enrolled